Medeon Biodesign (ROCO:6499) Scaled Net Operating Assets : 0.15 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Medeon Biodesign's operating assets for the quarter that ended in Mar. 2024 was NT$617.3 Mil. Medeon Biodesign's operating liabilities for the quarter that ended in Mar. 2024 was NT$176.2 Mil. Medeon Biodesign's Total Assets for the quarter that ended in Sep. 2023 was NT$2,980.8 Mil. Therefore, Medeon Biodesign's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.15.

Medeon Biodesign Scaled Net Operating Assets Historical Data

The historical data trend for Medeon Biodesign's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Scaled Net Operating Assets Chart

Medeon Biodesign Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.25

0.29

0.38

0.56

0.53

Medeon Biodesign Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.55	0.57	0.10	0.14	0.15

Competitive Comparison of Medeon Biodesign's Scaled Net Operating Assets

For the Medical Instruments & Supplies subindustry, Medeon Biodesign's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medeon Biodesign's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medeon Biodesign's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Medeon Biodesign's Scaled Net Operating Assets falls into.

Medeon Biodesign Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Medeon Biodesign's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2022 )
=	(Operating Assets (A: Dec. 2022 )	-	Operating Liabilities (A: Dec. 2022 ))	/	Total Assets (A: Dec. 2021 )
=	(2492.785	-	177.567)	/	4364.49
=	0.53

where

	Operating Assets		(A: Dec. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	4040.023	-	1547.238
=	2492.785

	Operating Liabilities		(A: Dec. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	376.477	-	162.224	-	36.686
=	177.567

Medeon Biodesign's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Sep. 2023 )
=	(617.305	-	176.239)	/	2980.829
=	0.15

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2557.756	-	1940.451
=	617.305

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	379.695	-	152.789	-	50.667
=	176.239

Medeon Biodesign Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Medeon Biodesign (ROCO:6499) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170

Website

http://www.medeonbio.com

Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign (ROCO:6499) Headlines

No Headlines